Magana Cathcart & McCarthy

Category Archives: Medical Device & Dangerous Drugs

Bottle of Pills

Juries Return Verdicts in First Two Bellwether Trials for Xarelto Victims

By Magaña Cathcart McCarthy |

The Xarelto litigation is now well underway, with two of four bellwether trials so far concluded. On May 3, a Louisiana federal jury returned a verdict in favor of the defense in the case titled Boudreaux vs Bayer et al. The second bellwether also resulted in a loss for the plaintiff when, on June… Read More »

Image of a spine

InFuse Spinal Fusion Device Blamed for Bone Overgrowth and Other Injuries

By Magaña Cathcart McCarthy |

The University of California has recently agreed to settle multiple plaintiffs’ claims that a surgeon employed by University of California Los Angeles (UCLA) who had financial ties to the device’s manufacturer conducted surgeries using the fusion device that resulted in painful side effects for the patients. The Medtronic InFuse bone graft medical device was… Read More »

hip replacement

$500 Million Jury Award to DePuy Hip Implant Victims Reduced

By Magaña Cathcart McCarthy |

Five individuals who experienced serious injuries after receiving DePuy metal-on-metal hip implants received a jury award of $500 million in damages in March of 2016. Recently, that award was reduced by a federal judge to $151 million. DePuy, a subsidiary of Johnson & Johnson, has been mired in litigation over their Pinnacle metal-on-metal hip… Read More »

A products liability sign

New Power Morcellator Device Receives FDA Approval

By Magaña Cathcart McCarthy |

Despite the substantial concerns over whether or not the devices can ever perform their job safely, a new power morcellator dev ice has been approved for the market by the U.S. Food and Drug Administration (FDA). In the past, power morcellators have been linked to the spread of cancers and are the subject of… Read More »

Woman next to a birth control sign.jpg.crdownload

FDA Recommends Black Box Warning for Permanent Contraceptive Essure

By Magaña Cathcart McCarthy |

After becoming linked to serious health complications for users, Essure, a form of permanent birth control, now carries a black box warning from the US Food and Drug Administration (FDA), and is being subjected to a mandatory clinical study to investigate whether or not the device carries excessive health risks for certain women. The… Read More »

Three-doctors

Johnson & Johnson Settles Thousands of Transvaginal Mesh Claims with $120M Payment

By Magaña Cathcart McCarthy |

Los Angeles personal injury & products liability attorneys Magaña, Cathcart & McCarthy report on $120 million settlement of transvaginal mesh claims.

Surgery-tools

California Plaintiff Awarded Nearly $80 Million for Injuries from Defective Hemorrhoid Stapler

By Magaña Cathcart McCarthy |

Los Angeles personal injury attorneys Magaña, Cathcart & McCarthy report on $80 million jury verdict for defective medical device in product liability case.

Medical-treatment

IVC Filters: Are They Worth the Risk?

By Magaña Cathcart McCarthy |

An IVC filter is a mechanical device inserted into a patient’s inferior vena cava (IVC), which is a major vein in the body delivering deoxygenated blood to the heart and lungs. Certain people are at risk of developing a blood clot in their legs known as a deep vein thrombosis (DVT), which can break… Read More »

Hospital room

Redesigned Medical Device that Spread Superbug Contamination at Los Angeles Hospital was not Approved by the FDA

By Magaña Cathcart McCarthy |

Last March we reported on the lawsuits being filed against medical device maker Olympus America for the spread of carbapenem-resistant Enterobacteriacae (CRE) linked to the use of a duodenoscope manufactured by Olympus America. CRE is a deadly bacteria that is so highly resistant to antibiotics that it is commonly called a Superbug. A deadly… Read More »

Tablets & capsules

Watch Out for Nursing Home Medication Errors

By Magaña Cathcart McCarthy |

Nursing home medication errors may be more common than you think. Federal regulations on quality of care even assume that a certain amount of medication errors will occur, although they require nursing homes to keep medication error rates below five percent and to not have any “significant” medication errors. The law defines a medication… Read More »

Designed and Powered by NextClient

© 2015 - 2017 Magaña, Cathcart & McCarthy.
All rights reserved.
This Custom WebShop™ website is designed by NextClient.com.

Contact Form Tab Close Menu